Wellpartner to Launch New Audit Tool, AccessCompare™, at July 340B Coalition Summer Conference in Washington, DC

Jul 13, 2015, 09:00 ET from Wellpartner

NEW YORK and PORTLAND, Ore., July 13, 2015 /PRNewswire/ -- Wellpartner, Inc., an industry-leading 340B optimization company, is pleased to announce the launch of AccessCompare, a new 340B reporting tool that analyzes Covered Entities' claims to ensure the highest levels of program compliance.

"AccessCompare addresses the previously unmet needs of Covered Entities who employ multiple data interfaces, claim qualification methodologies, pharmacy networks or contract pharmacy administrators in their 340B programs," stated James R. Love, CEO of Wellpartner.

Wellpartner's 340B expertise paired with proven technology development capabilities combine within AccessCompare™ to deliver the ability to increase program integrity at a time when 340B regulatory oversight and HRSA audits are increasing. AccessCompare™ applies Wellpartner's gold standard 340B claims qualification methodology to analyze and validate all of a Covered Entity's 340B claims, greatly reducing the lengthy manual oversight needed to ensure program compliance and audit readiness.  In short, AccessCompare™ helps Covered Entities attain the highest level of program integrity while maximizing 340B savings and community benefits.

Wellpartner is a Pinnacle Sponsor at next week's 340B Coalition Summer Conference and will be providing live demonstrations of AccessCompare at Booth #8 on July 13 -15.

About Wellpartner

Wellpartner is a leading provider of 340B optimization programs for a wide variety of safety net hospitals and clinics. Through it's wholly owned, URAC, ACHC and VIPPS accredited specialty pharmacy, Wellpartner dispenses pharmaceuticals to selected patients of these hospitals and clinics. In addition to AccessCompare, Wellpartner's product suite includes: 340BAccess a 100% outsourced solution for covered entities seeking a 340B contract pharmacy program; AccessConvergence which enables clients to greatly enhance their 340B programs by gaining access to previously "locked-away" specialty pharmaceutical prescriptions; and, AccessIntegra a state-of-the-art reporting and analytics tool. Today, more than 115 Covered Entities trust Wellpartner to optimize their 340B programs. 

Visit www.wellpartner.com for more information.

Contact:
Julee Whalin
212.547.5088
jwhalin@wellpartner.com

 

SOURCE Wellpartner



RELATED LINKS

http://www.wellpartner.com